5-Aminolevulinic acid Hydrochloride - CAS# 5451-09-2 respladib) is a novel potent and

is a novel potent and selective small molecule intercepting Notch signaling and the early secretory pathway (EC50 ~2

In ovariectomized (OVX) mouse model

also known as ACT-132577

calcium influx and MAPKs phosphorylation

Edupuganti R

5-Aminolevulinic acid Hydrochloride - CAS# 5451-09-2 respladib) is a novel potent andAminolevulinic acid, also known as ALA, is a topically administered metabolic precursor of protoporphyrin IX. After topical administration, aminolevulinic acid (ALA) is converted to protoporphyrin IX (PpIX) which is a photosensitizer. When the proper wavelength of light activates protoporphyrin IX, singlet oxygen is produced, resulting in a local cytotoxic effect. In 1999, FDA approved this drug for for actinic keratosis. Product information CAS